Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 9,182 shares at $228.50 ($2.1M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $2.1M NTRA by PRESIDENT, CLINICALDIAGNOSTICS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $228.50 | 80 | $18K | 0.9% |
| 2 | $229.96 | 878 | $202K | 9.5% |
| 3 | $229.96 | 878 | $202K | 9.5% |
| 4 | $230.84 | 576 | $133K | 6.3% |
| 5 | $230.84 | 576 | $133K | 6.3% |
| 6 | $232.33 | 850 |
| $197K |
| 9.3% |
| 7 | $232.33 | 850 | $197K | 9.3% |
| 8 | $233.24 | 600 | $140K | 6.6% |
| 9 | $233.24 | 600 | $140K | 6.6% |
| 10 | $234.00 | 16 | $4K | 0.2% |
| 11 | $230.77 | 1,639 | $378K | 17.8% |
| 12 | $230.77 | 1,639 | $378K | 17.8% |
| Total | $231.22 avg | 9,182 | $2.1M | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |